Coding the Future: Understanding 2026 CPT Revisions and Their Impact on Practice & Reimbursement

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - ACIST; Terumo Medical Corporation; Jannsen; GE Healthcare</li><li>Equity/Stock(s)/Options - Frond Medical; Summacor</li><li>Grant Support/Research Contract - Idorsia</li></ul>